IQVIA (IQV)
(Delayed Data from NYSE)
$208.10 USD
+1.29 (0.62%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $208.12 +0.02 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IQV 208.10 +1.29(0.62%)
Will IQV be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for IQV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IQV
Clinical Development Expertise Aids IQVIA (IQV), Costs High
Paychex (PAYX) to Report Q4 Earnings: What's in the Offing?
IQV: What are Zacks experts saying now?
Zacks Private Portfolio Services
EPAM Expands in Life Sciences Space With Odysseus Buyout
IQVIA (IQV) Announces Launch of Trial Technology Platform
Here's Why You Should Hold on to IQVIA (IQV) Stock for Now
Other News for IQV
Barclays Keeps Their Buy Rating on IQVIA Holdings (IQV)
Iqvia price target lowered by $20 at Barclays, here's why
5 Analysts Assess IQVIA Hldgs: What You Need To Know
Goldman’s top 50 high Sharpe Ratio stocks
IQVIA’s SmartSolve® eQMS Wins 2024 MedTech Breakthrough Award “Best Use of Artificial Intelligence in Healthcare”